Engineering and Characterization of a Long-Half-Life Relaxin Receptor RXFP1 Agonist-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineering and Characterization of a Long-Half-Life Relaxin Receptor RXFP1 Agonist

Published:2024-08-12 Issue:9 Volume:21 Page:4441-4449
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Erlandson Sarah C.¹,Wang Jialu²,Jiang Haoran²^ORCID,Osei-Owusu James¹,Rockman Howard A.²³^ORCID,Kruse Andrew C.¹^ORCID

Affiliation:

1. Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts 02115, United States

2. Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, United States

3. Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710, United States

Funder

Damon Runyon Cancer Research Foundation

National Heart, Lung, and Blood Institute

Harvard Medical School

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.4c00368

Reference47 articles.

1. Relaxin Family Peptides and Their Receptors

2. Activation of Orphan Receptors by the Hormone Relaxin

3. Anti‐fibrotic actions of relaxin

4. The actions of relaxin on the human cardiovascular system

5. Heart Disease and Relaxin: New Actions for an Old Hormone

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP